Investor · 1 deal
Every published round Dexcom took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Nutromics | Unnamed stage | 9 Sep 2022 | $20.5m | Lead | Startup Daily (Wed 3 Sep 2025), SmartCompany, Startup Daily (Fri 9 Sep 2022), @AuManufacturing |
Companies Dexcom has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Nutromics | 9 Sep 2022 | 1 | 1 |
Fund closes reported for Dexcom, as distinct from the investments it has made.
Companies Dexcom has backed that another company then bought. An exit for the holding, not a deal Dexcom did.
Stories naming Dexcom. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
LaunchVic profiles Nutromics, a wearable diagnostic patch maker whose co-founders joined the 30X30 scaleup program; the piece recalls a $2 million government grant and over US$14 million raised to date.
Wearable diagnostics developer Nutromics has raised $11 million from two unnamed family offices, after a prior $20 million round backed by Dexcom's venture arm, and appointed Dr Chris Roberts as non-executive chairperson.
Also SmartCompany·Techboard
Melbourne wearable diagnostics startup Nutromics raised US$14 million (A$20.5 million), led by Dexcom's venture arm with VU Venture Partners and Artesian, to fund clinical studies and expansion.